Clinical Trials Directory

Trials / Unknown

UnknownNCT03422315

Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection

Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection in Adult Patients With General Anesthesia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Zhongyuan Xu · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Propofol is a widely used sedative anesthetic, but there are large individual differences, which making different patients with different sensitivity to propofol. The aim of this study was to analyze the effects of age, height, body weight, Drinking, metabolic enzymes CYP2B6 and UGT1A9 on Pharmacological effects and pharmacokinetics of propofol, and to provide a reasonable reference for clinical anesthesia patients and evidence for individual dosage regimens.

Detailed description

Propofol is a widely used sedative anesthetic, but there are large individual differences, which making different patients with different sensitivity to propofol. In recent years, the concept of individualized administration came into being.Individual administration refers to according to the condition of patients,the drug's safety and efficacy, and pharmacokinetics, pharmacodynamics and clinical response ,then gives different dosing regimens for individual patients and promotes the development of rational drug use. Different people have differences metabolism of propofol, reported in the literature, genetic polymorphism, demographic characteristics, combined with drug and other variability factors, all of them will affect the pharmacokinetics and pharmacodynamics of propofol.The aim of this study was to analyze the effects of age, height, body weight, Drinking, metabolic enzymes CYP2B6 and UGT1A9 on Pharmacological effects and pharmacokinetics of propofol, and to provide a reasonable reference for clinical anesthesia patients and evidence for individual dosage regimens.

Conditions

Interventions

TypeNameDescription
DRUGPropofolinjection;2mg/kg;single-dose

Timeline

Start date
2018-09-03
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2018-02-05
Last updated
2021-06-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03422315. Inclusion in this directory is not an endorsement.

Population Pharmacokinetics and Clinical Individual Dosage Regimen of Propofoll Injection (NCT03422315) · Clinical Trials Directory